NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 179 filers reported holding NOVAVAX INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $905,000 | -40.0% | 431,031 | +102.1% | 0.15% | -36.8% |
Q3 2015 | $1,508,000 | -66.6% | 213,280 | -47.4% | 0.24% | -54.8% |
Q2 2015 | $4,521,000 | +0.6% | 405,830 | -25.3% | 0.53% | +1.9% |
Q1 2015 | $4,493,000 | +8.6% | 543,283 | -22.1% | 0.52% | -10.1% |
Q4 2014 | $4,137,000 | +119.1% | 697,679 | +54.1% | 0.58% | +50.3% |
Q3 2014 | $1,888,000 | -18.1% | 452,856 | -9.2% | 0.38% | -12.1% |
Q2 2014 | $2,304,000 | -8.1% | 498,793 | -9.9% | 0.44% | -3.3% |
Q1 2014 | $2,507,000 | -18.2% | 553,465 | -7.6% | 0.45% | -17.7% |
Q4 2013 | $3,066,000 | +204.5% | 598,749 | +87.8% | 0.55% | +173.1% |
Q3 2013 | $1,007,000 | – | 318,794 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |